Implementation Guide CH VACD
5.0.0 - trial-use Switzerland flag

This page is part of the CH VACD (R4) (v5.0.0: STU 5) based on FHIR (HL7® FHIR® Standard) R4. This is the current published version. For a full list of available versions, see the Directory of published versions

Example Immunization: TC1 Immunization by HCP2

Generated Narrative: Immunization TCA01-IMMUN3-HCP2-ORG2-ROLE

Author of the content: PractitionerRole

CH VACD Extension Immunization Medication Reference: Medication FSME-IMMUN CC Inj Susp sep Nadel

identifier: urn:oid:2.16.756.5.30.1.402.1.3.1.1.1/7f7a308a-63f7-4be1-a329-0a33e08b4645

status: Completed

vaccineCode: FSME-Immun CC

patient: Monika Wegmueller Female, DoB: 1967-02-10 ( Medical record number)

occurrence: 2021-08-01

recorded: 2021-08-02 00:00:00+0200

lotNumber: 12-34244

route: Intramuscular use

Performers

-Actor
*PractitionerRole

note: Der Patient hatte keinerlei Nebenwirkungen. (By Practitioner/TC-HCP2-C2 @2021-08-01)

ProtocolApplieds

-TargetDiseaseDoseNumber[x]
*Tickborne encephalitis1